RUBEN HERNAEZ RODRIGUEZ to Carcinoma, Hepatocellular
This is a "connection" page, showing publications RUBEN HERNAEZ RODRIGUEZ has written about Carcinoma, Hepatocellular.
Connection Strength
1.604
-
Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono? Gut. 2023 01; 72(1):7-9.
Score: 0.389
-
Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2022 12; 20(12):2818-2825.e1.
Score: 0.379
-
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma. Gut. 2022 03; 71(3):454-456.
Score: 0.361
-
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 05; 19(5):987-995.e1.
Score: 0.343
-
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis. Hepatology. 2024 01 01; 79(1):107-117.
Score: 0.106
-
Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
Score: 0.027